Author:
Delorme Richard,Betancur Catalina,Callebert Jacques,Chabane Nadia,Laplanche Jean-Louis,Mouren-Simeoni Marie-Christine,Launay Jean-Marie,Leboyer Marion
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference55 articles.
1. Alsobrook IJ, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL (1999). Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet 88: 669–675.
2. Alvarez JC, Gluck N, Arnulf I, Quintin P, Leboyer M, Pecquery R et al (1999). Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther 66: 617–624.
3. Arolt V, Lencer R, Nolte A, Muller-Myhsok B, Purmann S, Schurmann M et al (1996). Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet 67: 564–579.
4. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS (1992). The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry 53(Suppl): 17–28.
5. Bastani B, Arora RC, Meltzer HY (1991). Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biol Psychiatry 30: 131–139.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献